Dexcom

from Wikipedia, the free encyclopedia
DexCom, Inc.

logo
legal form Inc.
ISIN US2521311074
founding 1999
Seat San Diego , United StatesUnited StatesUnited States 
management Kevin Sayer
Number of employees 3,900 (2019)
sales $ 1.032 billion (2018)
Branch Medical devices
Website www.dexcom.com

DexCom, Inc. is a US company that develops, manufactures, and markets continuous measuring glucose sensors for diabetes patients. The main office is in San Diego .

history

Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received approval from the Food and Drug Administration for a continuous glucose measurement system that provides up to 288 readings every 24 hours for three days. The second generation, which provides seven-day readings, was approved in May 2007. In 2008, Dexcom announced that it would partner with Insulet Corporation, Animas Corporation and Edwards Lifesciences to develop a continuously measuring glucose sensor for intensive care units . The cooperation with Insulet was ended in 2013. In order to make the new generation G5 and G6 compatible with Tandem's insulin pumps, a contract was signed with Tandem Diabetes Care in 2015 . The devices were approved in 2016 and 2018.

Individual evidence

  1. ↑ Dexcom adding 500 jobs in Mesa . Retrieved September 19, 2019.
  2. ↑ Freedom Meditech raises $ 7 million ( s 7) August 2013. Retrieved on September 19 of 2019.
  3. ↑ Insulet Corporation and DexCom Announce Development Agreement (NASDAQ: DXCM) . In: Investor.shareholder.com . January 7, 2008. Retrieved December 3, 2015.
  4. ↑ DexCom ™ Announces Joint Development Agreement with Animas Corporation . In: Investor.shareholder.com . June 10, 2008. Retrieved April 4, 2016.
  5. ↑ Edwards Lifesciences and DexCom to Develop Continuous Glucose Monitoring Products for Hospital Market (NASDAQ: DXCM) . In: Investor.shareholder.com . November 10, 2008. Retrieved December 3, 2015.
  6. ^ Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems . In: PR Newswire . July 30, 2015. Accessed December 3, 2015.
  7. ↑ FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices . FDA. March 27, 2018. Retrieved March 27, 2018.